Why it was recalled
Presence of Foreign Tablets/Capsules: Lisinopril Tablets USP, 20mg found in a 1000 count bottle of Lisinopril Tablets USP, 10mg
Product description
Lisinopril Tablets USP, 10 mg, 1000 count bottles, Manufactured by: Lupin Limited, Nagpur INDIA, For BluePoint Laboratories NDC 68001-334-08
Lot numbers, UPCs & expiration codes
Lot # Q000232, exp. date 01/2022
Where it was sold
Product was distributed to OH and may have been further distributed throughout the United States.
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-1413-2020
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- Jul 17, 2020
- FDA report date
- Aug 5, 2020
- Quantity
- 11,688 bottles
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- Lupin Pharmaceuticals Inc.
Original FDA data
Every field from FDA enforcement report D-1413-2020, exactly as published.
Show all FDA fields
- City
- Baltimore
- State
- MD
- Status
- Terminated
- Country
- United States
- Event ID
- 86053
- Address
- Harborplace Tower
- Address (line 2)
- 111 S Calvert St Fl 21st
- Code information
- Lot # Q000232, exp. date 01/2022
- Postal code
- 21202-6174
- Report date
- Aug 5, 2020
- Product type
- Drugs
- Recall number
- D-1413-2020
- Classification
- Class II
- Recalling firm
- Lupin Pharmaceuticals Inc.
- Product quantity
- 11,688 bottles
- Termination date
- Aug 26, 2021
- Reason for recall
- Presence of Foreign Tablets/Capsules: Lisinopril Tablets USP, 20mg found in a 1000 count bottle of Lisinopril Tablets USP, 10mg
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- Lisinopril Tablets USP, 10 mg, 1000 count bottles, Manufactured by: Lupin Limited, Nagpur INDIA, For BluePoint Laboratories NDC 68001-334-08
- Distribution pattern
- Product was distributed to OH and may have been further distributed throughout the United States.
- Recall initiation date
- Jul 17, 2020
- Initial firm notification
- Letter
- Center classification date
- Jul 28, 2020